BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 26264618)

  • 21. Novel Humoral Prognostic Markers in Small-Cell Lung Carcinoma: A Prospective Study.
    Gozzard P; Chapman C; Vincent A; Lang B; Maddison P
    PLoS One; 2015; 10(11):e0143558. PubMed ID: 26606748
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lymphopenia is an independent predictor of inferior outcome in papillary renal cell carcinoma.
    Mehrazin R; Uzzo RG; Kutikov A; Ruth K; Tomaszewski JJ; Dulaimi E; Ginzburg S; Abbosh PH; Ito T; Corcoran AT; Chen DY; Smaldone MC; Al-Saleem T
    Urol Oncol; 2015 Sep; 33(9):388.e19-25. PubMed ID: 25027688
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nomograms Predict Overall Survival for Patients with Small-Cell Lung Cancer Incorporating Pretreatment Peripheral Blood Markers.
    Xie D; Marks R; Zhang M; Jiang G; Jatoi A; Garces YI; Mansfield A; Molina J; Yang P
    J Thorac Oncol; 2015 Aug; 10(8):1213-20. PubMed ID: 26200277
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The relationship between splenic dose and radiation-induced lymphopenia.
    Ma Y; Kong Y; Zhang S; Peng Y; Xu M; Zhang J; Xu H; Hong Z; Xing P; Qian J; Zhang L
    J Radiat Res; 2024 May; 65(3):337-349. PubMed ID: 38718391
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prophylactic cranial irradiation-related lymphopenia affects survival in patients with limited-stage small cell lung cancer.
    Fan X; Yang L; Qin W; Zou B; Fan B; Wang S; Wang L
    Heliyon; 2023 Jun; 9(6):e16483. PubMed ID: 37251477
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic Implication of the Absolute Lymphocyte to Absolute Monocyte Count Ratio in Patients With Classical Hodgkin Lymphoma Treated With Doxorubicin, Bleomycin, Vinblastine, and Dacarbazine or Equivalent Regimens.
    Vassilakopoulos TP; Dimopoulou MN; Angelopoulou MK; Petevi K; Pangalis GA; Moschogiannis M; Dimou M; Boutsikas G; Kanellopoulos A; Gainaru G; Plata E; Flevari P; Koutsi K; Papageorgiou L; Telonis V; Tsaftaridis P; Sachanas S; Yiakoumis X; Tsirkinidis P; Viniou NA; Siakantaris MP; Variami E; Kyrtsonis MC; Meletis J; Panayiotidis P; Konstantopoulos K
    Oncologist; 2016 Mar; 21(3):343-53. PubMed ID: 26921291
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of Posttreatment Lymphopenia and Elevated Neutrophil-to-Lymphocyte Ratio With Poor Clinical Outcomes in Patients With Human Papillomavirus-Negative Oropharyngeal Cancers.
    Lin AJ; Gang M; Rao YJ; Campian J; Daly M; Gay H; Oppelt P; Jackson RS; Rich J; Paniello R; Zevallos J; Hallahan D; Adkins D; Thorstad W
    JAMA Otolaryngol Head Neck Surg; 2019 May; 145(5):413-421. PubMed ID: 30920592
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Absolute lymphocyte count: a potential prognostic factor for Merkel cell carcinoma.
    Johnson ME; Zhu F; Li T; Wu H; Galloway TJ; Farma JM; Perlis CS; Turaka A
    J Am Acad Dermatol; 2014 Jun; 70(6):1028-35. PubMed ID: 24666998
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interaction between lymphopenia, radiotherapy technique, dosimetry, and survival outcomes in lung cancer patients receiving combined immunotherapy and radiotherapy.
    Chen D; Patel RR; Verma V; Ramapriyan R; Barsoumian HB; Cortez MA; Welsh JW
    Radiother Oncol; 2020 Sep; 150():114-120. PubMed ID: 32525003
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neutrophil-Lymphocyte Ratio and Absolute Lymphocyte Count as Prognostic Markers in Patients Treated with Curative-intent Radiotherapy for Non-small Cell Lung Cancer.
    Punjabi A; Barrett E; Cheng A; Mulla A; Walls G; Johnston D; McAleese J; Moore K; Hicks J; Blyth K; Denholm M; Magee L; Gilligan D; Silverman S; Qureshi M; Clinch H; Hatton M; Philipps L; Brown S; O'Brien M; McDonald F; Faivre-Finn C; Hiley C; Evison M
    Clin Oncol (R Coll Radiol); 2021 Aug; 33(8):e331-e338. PubMed ID: 33863615
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predictive significance of surgery-induced lymphopenia on the survival after curative resection for locally advanced gastric cancer: a retrospective cohort analysis.
    Aizawa M; Yabusaki H; Matsuki A; Bamba T; Nakagawa S
    World J Surg Oncol; 2023 Jan; 21(1):7. PubMed ID: 36647123
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Surgical resection should be considered for stage I and II small cell carcinoma of the lung.
    Weksler B; Nason KS; Shende M; Landreneau RJ; Pennathur A
    Ann Thorac Surg; 2012 Sep; 94(3):889-93. PubMed ID: 22429675
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lymphopenia as a Potential Predictor of Ipsilateral Breast Tumor Recurrence in Early Breast Cancer.
    Cho O; Chun M; Kim SW; Jung YS; Yim H
    Anticancer Res; 2019 Aug; 39(8):4467-4474. PubMed ID: 31366546
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Baseline lymphopenia should not be used as exclusion criteria in early clinical trials investigating immune checkpoint blockers (PD-1/PD-L1 inhibitors).
    Sun R; Champiat S; Dercle L; Aspeslagh S; Castanon E; Limkin EJ; Baldini C; Postel-Vinay S; Hollebecque A; Massard C; Ammari S; Deutsch E; Soria JC; Marabelle A; Ferté C
    Eur J Cancer; 2017 Oct; 84():202-211. PubMed ID: 28826073
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The prognostic factors in the elderly patients with small cell lung cancer: a retrospective analysis from a single cancer institute.
    Liu S; Guo H; Kong L; Li H; Zhang Y; Zhu H; Yu J
    Int J Clin Exp Pathol; 2015; 8(9):11033-41. PubMed ID: 26617821
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Postradiotherapy persistent lymphopenia as a poor prognostic factor in patients with cervical cancer receiving radiotherapy: a single-center, retrospective study.
    Taguchi A; Furusawa A; Ito K; Nakajima Y; Shimizuguchi T; Hara K; Takao M; Kashiyama T; Kino N; Karasawa K; Yasugi T
    Int J Clin Oncol; 2020 May; 25(5):955-962. PubMed ID: 31960184
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic Factors and Treatment of Early-stage Small-cell Lung Cancer.
    Käsmann L; Bolm L; Janssen S; Rades D
    Anticancer Res; 2017 Mar; 37(3):1535-1537. PubMed ID: 28314330
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prospective study of proton-beam radiation therapy for limited-stage small cell lung cancer.
    Rwigema JM; Verma V; Lin L; Berman AT; Levin WP; Evans TL; Aggarwal C; Rengan R; Langer C; Cohen RB; Simone CB
    Cancer; 2017 Nov; 123(21):4244-4251. PubMed ID: 28678434
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Malignant Pleural Effusion at Presentation in Patients with Small-Cell Lung Cancer.
    Shojaee S; Singh I; Solsky I; Nana-Sinkam P
    Respiration; 2019; 98(3):198-202. PubMed ID: 31121583
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lymphocyte Count Kinetics, Factors Associated with the End-of-Radiation-Therapy Lymphocyte Count, and Risk of Infection in Patients with Solid Malignant Tumors Treated with Curative-Intent Radiation Therapy.
    Terrones-Campos C; Ledergerber B; Vogelius IR; Specht L; Helleberg M; Lundgren J
    Int J Radiat Oncol Biol Phys; 2019 Nov; 105(4):812-823. PubMed ID: 31344435
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.